Search
for

    Glossary Erlotinib

    medication that inhibits cancer cell growth by targeting EGFR

    Erlotinib is a medication used to treat certain types of cancer, such as non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By blocking this receptor, erlotinib can help slow down or stop the progression of the disease.

    Research 10 of 236

    1. Persistent hair growth during treatment with the EGFR inhibitor erlotinib Dermatology Online Journal · 2009 · 39 citations
    2. A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib Journal of Cutaneous Pathology · 2009 · 33 citations
    3. Scarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib Journal of the American Academy of Dermatology · 2011 · 32 citations
    4. A Case of Cicatricial Alopecia Associated with Erlotinib Annals of Dermatology · 2011 · 25 citations
    5. Folliculitis decalvans associated with erlotinib Clinical and Experimental Dermatology · 2010 · 25 citations
    6. Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture 2014 · 15 citations
    7. Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer Journal of thoracic oncology · 2006 · 12 citations
    8. Erlotinib-Associated Alopecia in a Lung Cancer Patient Journal of Thoracic Oncology · 2007 · 8 citations
    9. Loose anchoring of anagen hairs and pili torti due to erlotinib International Journal of Trichology · 2016 · 5 citations
    10. Prevention of erlotinib-induced folliculitis with doxycycline Dermatologic Therapy · 2016 · 3 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →